Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group
Open Access
- 30 September 2014
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 50 (15), 2519-2531
- https://doi.org/10.1016/j.ejca.2014.07.002
Abstract
No abstract availableFunding Information
- Fondation Saint Luc
- Fondation contre la Cancer
- FRS-FNRS Télévie
- Belgian non profit organisations
- French Ministry of Health (PHRC)
- Cancer Research UK
- National Institute of Health research, UK
- Fonds Cancer/FOCA
This publication has 98 references indexed in Scilit:
- 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Early bone marrow metastasis detection: The additional value of FDG-PET/CT vs. CT imagingBiomedicine & Pharmacotherapy, 2012
- 18‐FDG PET/CT assessment of basal cell carcinoma with vismodegibCancer Medicine, 2012
- Biochemical markers of bone turnover and clinical outcomes in men with prostate cancerUrologic Oncology, 2012
- Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRIClinical & Experimental Metastasis, 2011
- Fast dixon whole‐body MRI for detecting distant cancer metastasis: a preliminary clinical studyJournal of Magnetic Resonance Imaging, 2011
- Imaging metastatic bone disease from carcinoma of the prostateBritish Journal of Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsBritish Journal of Cancer, 2007
- MR imaging of therapy-induced changes of bone marrowEuropean Radiology, 2006